Sinovac Obtains Production License for H1N1 Vaccine
- Posted on 09 September 2009
Sinovac Biotech has announced that the State Food and Drug Administration (SFDA) has approved the registration application for Panflu.1, a H1N1 vaccine, and has issued a production license for this vaccine.
Following results which showed that the vaccine has a good safety and immunogenicity profile, the company announced the findings of an experts' evaluation conference organized by the SFDA on August 30 and 31.
The experts agreed that the vaccine is suitable for all people from three to 60 years old on a single shot vaccination schedule.
